Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nimble Therapeutics

Request full access

Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery

Madison, United StatesFounded 2019Biotech & Life Sciences

About Nimble Therapeutics

Nimble Therapeutics is at the forefront of developing oral therapies for immune-mediated diseases, leveraging a proven discovery engine to accelerate the advancement of their pipeline into clinical trials. The company focuses on creating peptide-based treatments that mirror the effects of established therapies, aiming to improve clinical outcomes and patient convenience. Nimble's core platform integrates various approaches to expedite the discovery and development of oral peptide therapies, enabling rapid screening and a deeper understanding of molecular interactions. This optimization process enhances parameters such as potency, stability, gut permeability, half-life, and metabolism. Nimble serves clients in the pharmaceutical and biotechnology sectors, operating within the niche market of peptide therapeutics. The business model revolves around the discovery and development of high-impact medicines, progressing them through clinical trials, and eventually bringing them to market. Revenue is generated through partnerships, licensing agreements, and the commercialization of their proprietary therapies.

Source: Dealroom company data

Nimble Therapeutics in the Madison ecosystem

Live from Dealroom

The Nimble Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Telegraph Hill Partners
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Nimble Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.